300434.SZ Stock Analysis
30
Neutral
Based on Eyestock quantitative analysis, 300434.SZ`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Market cap $B
0.147
Dividend yield
1.45 %
Shares outstanding
401.74 B
Sichuan Goldstone Asia Pharmaceutical, Inc. engages in the research and development and application of steel reinforced plastic composite pipe technology and machinery. The company is headquartered in Chengdu, Sichuan and currently employs 1,935 full-time employees. The company went IPO on 2015-04-24. Its main products include health products, cracks and small cracks. The firm is also engaged in the machinery manufacturing business, as well as property leasing and management business. Its machinery products mainly include steel reinforced plastic pipe production line, bead winding steel reinforced pipe production line, production line equipment parts and other equipment. The firm mainly operates its businesses in domestic market.